
Regencell Investors Face June 23 Deadline in Securities Fraud Lawsuit
Investors who purchased Regencell Bioscience Holdings Limited securities between October 28, 2024, and October 31, 2025, face a June 23, 2026, deadline to seek lead plaintiff status. Rosen Law Firm, which filed the class action, is currently organizing claimants who suffered significant financial losses during the period.









/bmi/media/post_banners/685374a708a95156958d6658a6e64c51d2d6e73262d48b69d1988c2ac58cb616.jpg)















